A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors
Clinical trial NCT05109975 · TERMINATED
Trial details
- NCT number
- NCT05109975
- Sponsor
- Debiopharm International SA
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2026-04-24
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.